The pharmaceutical industry pipeline forecasts that 30 percent of future commercial molecules will be biologics. This presents a challenge to pharmaceutical companies, since biological drugs are difficult to deliver to the human body.
The most common form of drug delivery, the oral tablet, is unsuitable for most biologics since they are mostly protein-based and they are destroyed in the digestive process. Therefore, drug delivery by injection is often the chosen method of administration. Celanese actively supports development of innovative injection devices through our materials and technology innovations.
Let us help
Contact us for help with customization